Infliximab has emerged as one of the most impactful biologic therapies for treating autoimmune and inflammatory disorders. As a monoclonal antibody designed to inhibit tumor necrosis factor-alpha (TNF-α), infliximab plays a crucial role in managing chronic conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriasis. Its ability t... https://www.databridgemarketresearch.com/reports/global-infliximab-market